| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
| HSP90B1 |
HSP90B1, TRA1: Endoplasmin precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.265 |
Evidence |
|
| CSNK1E |
CSNK1E: Casein kinase I isoform epsilon |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| ITGB3 |
ITGB3, GP3A: Integrin beta-3 precursor |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| SNAPC4 |
SNAPC4, SNAP190: snRNA-activating protein complex subunit 4 |
TGIF2 |
TGIF2: Homeobox protein TGIF2 |
0.265 |
Evidence |
|
| ROCK2 |
ROCK2, KIAA0619: Rho-associated protein kinase 2 |
SNCB |
SNCB: Beta-synuclein |
0.265 |
Evidence |
|
| SRPK2 |
SRPK2: Serine/threonine-protein kinase SRPK2 |
JAK1 |
|
0.265 |
Evidence |
|
| CFH |
CFH, HF, HF1, HF2: Complement factor H precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
0.265 |
Evidence |
|
| CFHR2 |
CFHR2, CFHL2, FHR2, HFL3: Complement factor H-related protein 2 precursor |
SERPINA3 |
IPI00550991 |
0.265 |
Evidence |
|
| A2M |
A2M, FWP007: Alpha-2-macroglobulin precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
0.265 |
Evidence |
|
| ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
STK24 |
STK24, MST3, STK3: Serine/threonine-protein kinase 24 |
0.265 |
Evidence |
|
| NPR1 |
NPR1, ANPRA: Atrial natriuretic peptide receptor A precursor |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.265 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
PLD2 |
PLD2: Phospholipase D2 |
0.265 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
0.265 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
STK10 |
STK10: Uncharacterized protein STK10 |
0.265 |
Evidence |
|
| SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| OSBP |
OSBP, OSBP1: Oxysterol-binding protein 1 |
MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
0.265 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
0.265 |
Evidence |
|
| HSF2 |
HSF2, HSTF2: Heat shock factor protein 2 |
BATF |
BATF: Basic leucine zipper transcriptional factor ATF-like |
0.265 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
0.265 |
Evidence |
|
| COL3A1 |
COL3A1: Collagen alpha-1(III) chain precursor |
TNC |
TNC, HXB: Tenascin precursor |
0.265 |
Evidence |
|
| SCRIB |
SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL: Protein LAP4 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
0.265 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
0.265 |
Evidence |
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
JMJD1A |
JMJD1A, JHDM2A, JMJD1, KIAA0742: JmjC domain-containing histone demethylation pr |
0.265 |
Evidence |
|
- 
- 
-